Shioto Suzuki
- Oncology top 5%
- HER2/EGFR in Cancer Research 5
- Peptidase Inhibition and Analysis 4
-
- Lung Cancer Treatments and Mutations 6
- Sarcoma Diagnosis and Treatment 4
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Surgery top 10%
-
- Multiple Myeloma Research and Treatments 5
-
- PI3K/AKT/mTOR signaling in cancer 5
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 4
- Co-authors
- Akishi OoiYoh DobashiMitsuhiko HanawaYasuhisa TakedaKoji KonoHideki FujiiTetsu YamaneKumiko Nakazawa
- Journals
- SHILAP Revista de lepidopterología (2 papers)Cancer (2 papers)Scientific Reports (1 paper)
In The Last Decade
Shioto Suzuki
47 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 88
- Oncology 763
- Pulmonary and Respiratory Medicine 643
- Cancer Research 189
- Pathology and Forensic Medicine 211
- Surgery 468
Countries citing papers authored by Shioto Suzuki
This map shows the geographic impact of Shioto Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shioto Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shioto Suzuki more than expected).
Fields of papers citing papers by Shioto Suzuki
This network shows the impact of papers produced by Shioto Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shioto Suzuki. The network helps show where Shioto Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shioto Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 4 | |
| 3 | 2021 | 14 | |
| 4 | 2018 | 2 | |
| 5 | 2015 | 11 | |
| 6 | 2014 | 4 | |
| 7 | 2014 | 19 | |
| 8 | 2012 | 6 | |
| 9 | 2010 | 5 | |
| 10 | 2010 | 15 | |
| 11 | Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma. | 2009 | 26 |
| 12 | 2009 | 62 | |
| 13 | 2009 | 3 | |
| 14 | 2008 | 44 | |
| 15 | 2005 | 250 | |
| 16 | 2005 | 196 | |
| 17 | 2004 | 15 | |
| 18 | 2004 | 29 | |
| 19 | 2003 | 64 | |
| 20 | 2002 | 12 |
About Shioto Suzuki
Shioto Suzuki is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Multiple Myeloma Research and Treatments (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), HER2/EGFR in Cancer Research (5 papers), Peptidase Inhibition and Analysis (4 papers), Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (763 citations), Pulmonary and Respiratory Medicine (643 citations) and Cancer Research (189 citations). Shioto Suzuki has collaborated with scholars based in Japan, Sweden and India. Frequent co-authors include Akishi Ooi, Yoh Dobashi, Mitsuhiko Hanawa, Yasuhisa Takeda, Koji Kono, Hideki Fujii, Tetsu Yamane, Kumiko Nakazawa, Nobuyuki Enomoto and Takuo Takehana. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.